tiprankstipranks
Entera Bio reports Phase 1 data of oral PTH peptide candidate at ENDO 2024
PremiumThe FlyEntera Bio reports Phase 1 data of oral PTH peptide candidate at ENDO 2024
9M ago
Entera Bio appoints Wagman as Key Clinical Advisor, SAB member
Premium
The Fly
Entera Bio appoints Wagman as Key Clinical Advisor, SAB member
9M ago
Entera Bio to present Phase 1 data from EB612 at ENDO 2024
Premium
The Fly
Entera Bio to present Phase 1 data from EB612 at ENDO 2024
10M ago
Entera Bio announces key milestone for Oral PTH1-34 peptide
PremiumThe FlyEntera Bio announces key milestone for Oral PTH1-34 peptide
11M ago
Entera Bio announces PK data from oral GLP-2 peptide tablet treatment
Premium
The Fly
Entera Bio announces PK data from oral GLP-2 peptide tablet treatment
11M ago
Entera Bio management to meet virtually with Oppenheimer
Premium
The Fly
Entera Bio management to meet virtually with Oppenheimer
11M ago
Entera Bio management to meet with Oppenheimer
PremiumThe FlyEntera Bio management to meet with Oppenheimer
12M ago
Entera Bio management to meet with Oppenheimer
Premium
The Fly
Entera Bio management to meet with Oppenheimer
12M ago
Entera Bio management to meet with Oppenheimer
Premium
The Fly
Entera Bio management to meet with Oppenheimer
12M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100